Qiang Tian

Title: Qiang Tian: Innovator in Cancer Research

Introduction

Qiang Tian is a prominent inventor based in Seattle, WA, known for his significant contributions to cancer research. With a total of three patents to his name, he has developed innovative methods that enhance our understanding of cancer biology.

Latest Patents

One of Qiang Tian's latest patents is a method of detecting the phosphorylation state of beta-catenin. This invention involves purified molecules, including antibodies, that specifically bind to murine β-catenin phosphorylated at the amino acid position Serine, as well as to its mammalian orthologs, including human orthologs. The patent also provides methods for making and using these purified molecules, along with kits containing them. Another notable patent is focused on the use of gene expression signatures to determine cancer grade. This method is based on the over- and under-expression of 214 genes that characterize expression patterns in CD133 cells, providing valuable insights into cancer grading.

Career Highlights

Throughout his career, Qiang Tian has worked with esteemed institutions such as the Stowers Institute for Medical Research and the Institute for Systems Biology. His work has significantly advanced the field of cancer research, particularly in understanding the molecular mechanisms underlying cancer progression.

Collaborations

Qiang Tian has collaborated with notable scientists, including Leroy Hood and Xi C He. These collaborations have further enriched his research and contributed to the development of innovative solutions in cancer diagnostics and treatment.

Conclusion

Qiang Tian's work exemplifies the impact of innovative research in the field of cancer biology. His patents and collaborations highlight his commitment to advancing our understanding of cancer and improving diagnostic methods.